MIRA
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ: MIRA · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$1.05
+2.94% today
Updated 2026-04-30
Market cap
$42.86M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | — | — | — | $8.53M | — | — |
| Gross profit | — | — | — | $-8.53M | — | — |
| Gross margin | — | — | — | — | — | — |
| R&D | $14647.00 | $684447.00 | $2.35M | $1.57M | $3.31M | $1.72M |
| SG&A | $158946.00 | $770115.00 | $2.99M | $6.50M | $4.71M | $8.77M |
| Operating income | $-67629.00 | $-2.15M | $-7.05M | $-8.53M | $-8.02M | $-10.49M |
| Operating margin | — | — | — | — | — | — |
| EBITDA | $-67629.00 | $-2.15M | $-7.05M | $-8.53M | $-8.02M | $-10.49M |
| EBITDA margin | — | — | — | — | — | — |
| EBIT | $-270517.00 | $-2.15M | $-7.05M | $-11.98M | $-8.02M | — |
| Interest expense | $364.00 | $24374.00 | $10250.00 | $3.46M | $165669.00 | — |
| Income tax | $-202.00 | $-2152.00 | $-7047.00 | $-8526.00 | — | — |
| Effective tax rate | 0.3% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% |
| Net income | $-67993.00 | $-2.18M | $-7.06M | $-11.98M | $-7.85M | $-10.44M |
| Net income growth (YoY) | — | -3101.1% | -224.3% | -69.8% | +34.5% | -33.0% |
| Profit margin | — | — | — | — | — | — |